Unveiling Novel ADC Designs that Drive Improved Clinical Outcomes

11:45 am - Tuesday 9th March 2027

  • Featuring an update on clinical progress for next-generation ADCs, IKS014 and IKS03
  • Differentiating programmes through ADC design to address competitive landscape
  • Spotlighting ADC innovation that is paving the way for novel payloads

Speakers:

Chief Scientific Officer
Iksuda Therapeutics